Christopher Acone is a Torrance, California based Periodontics who is specialized in Periodontology. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 3220 Sepulveda Blvd, Suite 101, Torrance. Patients can reach him at 424-263-4919.
Christopher Acone is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
Christopher Acone speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Christopher Acone
Specialization:
Periodontics
Gender:
Male
Credentials:
DDS
Accepts Medicare Assignment:
May Accept
Practice Address:
3220 Sepulveda Blvd, Suite 101, Torrance, California, 90505-2744
Phone:
424-263-4919
Fax:
424-263-4921
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
5597995589
Enrollment ID:
I20140314000117
NPI Number:
1659576551
NPI Enumeration Date:
19 Jun, 2007
NPI Last Update On:
10 Sep, 2012
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3220 Sepulveda Blvd, Suite 101 Torrance, California
Zip:
90505-2744
Phone Number:
424-263-4919
Fax Number:
424-263-4921
Patients can reach Christopher Acone at 3220 Sepulveda Blvd, Suite 101, Torrance, California or can call to book an appointment on 424-263-4919. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.